Zoetis Inc. (NYSE:ZTS) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
reporting its financial results for the first quarter of 2017 and
reaffirming its guidance for full year 2017. A copy of the
Companys press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K.
is being furnished to the Securities and Exchange Commission and
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference into any filing of
the Company under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference
in such a filing.
|
(d)
|
Exhibits
|
Zoetis financial results for the first quarter of 2017 and
reaffirming its guidance for full year 2017.
About Zoetis Inc. (NYSE:ZTS)
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness. Zoetis Inc. (NYSE:ZTS) Recent Trading Information
Zoetis Inc. (NYSE:ZTS) closed its last trading session down -0.88 at 55.59 with 5,795,937 shares trading hands.